Phenotype—genotype relationships in monogenic disease: lessons from the thalassaemias
暂无分享,去创建一个
[1] Jennifer J. Pointon,et al. Global prevalence of putative haemochromatosis mutations. , 1997, Journal of medical genetics.
[2] R. Snow,et al. A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya. , 1997, Human molecular genetics.
[3] Y. C. Chang,et al. Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2 , 1992 .
[4] M. Alpers,et al. alpha+-Thalassemia protects children against disease caused by other infections as well as malaria. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[5] A. Oppenheim,et al. Genetic analysis of β‐thalassemia intermedia in Israel: Diversity of mechanisms and unpredictability of phenotype , 1997, American journal of hematology.
[6] D. Girelli,et al. Haemochromatosis in patients with β‐thalassaemia trait , 2000, British journal of haematology.
[7] A. Wilkie,et al. Genetic heterogeneity in heterocellular hereditary persistence of fetal hemoglobin. , 1997, Blood.
[8] T. Huisman,et al. DNA sequence variation associated with elevated fetal G gamma globin production. , 1985, Blood.
[9] M. Romano,et al. Clinical features of thalassemia intermedia in Italy. , 1987, Birth defects original article series.
[10] D. Weatherall,et al. Association of thalassaemia intermedia with a beta‐globin gene haplotype , 1987, British journal of haematology.
[11] N. Olivieri,et al. Hemoglobin E/β Thalassemia: The Canadian Experience , 1998 .
[12] C. Newbold,et al. High incidence of malaria in α-thalassaemic children , 1996, Nature.
[13] S. Deutsch,et al. Severe inclusion body β‐thalassaemia with haemolysis in a patient double heterozygous for β°‐thalassaemia and quadruplicated α‐globin gene arrangement of the anti‐4.2 type , 1999 .
[14] J. Clegg,et al. THE CLINICAL AND MOLECULAR HETEROGENEITY OF THE THALASSEMIA SYNDROMES * , 1980, Annals of the New York Academy of Sciences.
[15] M. Idelson,et al. Bone mineral metabolism in adults with β‐thalassaemia major and intermedia , 2000 .
[16] J. B. Clegg,et al. The thalassaemia syndromes , 1965 .
[17] W. Wanachiwanawin,et al. Effect of pyrexia in the formation of intraerythrocytic inclusion bodies and vacuoles in haemolytic crisis of haemoglobin H disease , 1994, European journal of haematology.
[18] G. Lathrop,et al. Dissecting the loci controlling fetal haemoglobin production on chromosomes 11p and 6q by the regressive approach , 1996, Nature Genetics.
[19] E. Schwartz. The silent carrier of beta thalassemia. , 1969, The New England journal of medicine.
[20] N. Andrews,et al. Iron homeostasis: insights from genetics and animal models , 2000, Nature Reviews Genetics.
[21] S. Perrotta,et al. Osteoporosis in β‐thalassaemia major patients: analysis of the genetic background , 2000, British journal of haematology.
[22] D. Weatherall. Pathophysiology of thalassaemia. , 1998, Bailliere's clinical haematology.
[23] J. Clegg,et al. A novel α-globin gene arrangement in man , 1980, Nature.
[24] D. Kwiatkowski,et al. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria , 1994, Nature.
[25] A. Cao,et al. Hyperbilirubinaemia in heterozygous β‐thalassaemia is related to co‐inherited Gilbert's syndrome , 1997, British journal of haematology.
[26] G. Stamatoyannopoulos,et al. The molecular basis of blood diseases , 1987 .
[27] S. Thein,et al. Nontransfusional Iron Overload in Thalassemia: Association with Hereditary Hemochromatosis , 1998, Annals of the New York Academy of Sciences.
[28] C. Scriver,et al. The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.
[29] N. Olivieri,et al. Thalassaemia in Sri Lanka: implications for the future health burden of Asian populations , 2000, The Lancet.
[30] R. Galanello,et al. Molecular analysis of beta zero-thalassemia intermedia in Sardinia. , 1989, Blood.
[31] E. Kanavakis,et al. The triplicated alpha gene locus and beta thalassaemia. , 1983, British journal of haematology.
[32] D. Weatherall. Thalassemia in the Next Millennium: Keynote Address a , 1998, Annals of the New York Academy of Sciences.
[33] G. Stamatoyannopoulos,et al. Inclusion-Body β-Thalassemia Trait , 1974 .
[34] Andrew J. McMichael,et al. Common West African HLA antigens are associated with protection from severe malaria , 1991, Nature.
[35] K. Summers. Relationship between genotype and phenotype in monogenic diseases: Relevance to polygenic diseases , 1996, Human mutation.
[36] D. Weatherall. Gene therapy: Repairing haemoglobin disorders with ribozymes , 1998, Current Biology.
[37] S. Thein. IS IT DOMINANTLY INHERITED β THALASSAEMIA OR JUST A β‐CHAIN VARIANT THAT IS HIGHLY UNSTABLE? , 1999 .
[38] A. Kutlar,et al. A C----T substitution at nt--101 in a conserved DNA sequence of the promotor region of the beta-globin gene is associated with "silent" beta-thalassemia. , 1989, Blood.
[39] J. Clegg,et al. MOLECULAR BASIS FOR MILD FORMS OF HOMOZYGOUS BETA-THALASSAEMIA , 1981, The Lancet.
[40] T. Huisman,et al. Possible factors influencing the haemoglobin and fetal haemoglobin levels in patients with β‐thalassaemia due to a homozygosity for the IVS‐I‐6 (T→C) mutation , 1994, British journal of haematology.
[41] A. Kutlar,et al. Clinical and genetic heterogeneity in black patients with homozygous beta-thalassemia from the southeastern United States. , 1988, Blood.
[42] P. Grisanti,et al. Silent thalassemias: genotypes and phenotypes. , 1997, Haematologica.
[43] M Farrall,et al. Genetic influences on F cells and other hematologic variables: a twin heritability study. , 2000, Blood.
[44] Y. Kan,et al. Mild thalassemia: the result of interactions of alpha and beta thalassemia genes. , 1970, The Journal of clinical investigation.
[45] J. Clegg,et al. Why are hemoglobin F levels increased in HbE/beta thalassemia? , 1999, Blood.
[46] D. J. Weatherall,et al. 4 Pathophysiology of thalassaemia , 1998 .
[47] Wonke. BONE DISEASE IN β‐THALASSAEMIA MAJOR , 1998 .
[48] J. Clegg,et al. A Genetically Determined Disorder with Features both of Thalassaemia and Congenital Dyserythropoietic Anaemia , 1973, British journal of haematology.
[49] A. Dawson. Bailliere's Clinical Haematology - International Practice and Research , 1988 .
[50] D. Weatherall,et al. Thalassaemia intermedia. , 1987, Blood reviews.
[51] W. Wood,et al. The triplicated α gene locus and β thalassaemia , 1983 .
[52] J. Clegg,et al. The Clinical and Biosynthetic Characterization of αβ‐Thalassaemia , 1972, British journal of haematology.
[53] H. Bunn. Pathogenesis and treatment of sickle cell disease. , 1997, The New England journal of medicine.
[54] A. Sachs,et al. Messenger RNA degradation in eukaryotes , 1993, Cell.
[55] ScienceDirect. Baillière's clinical haematology , 1998 .
[56] M. Hentze,et al. Binary specification of nonsense codons by splicing and cytoplasmic translation , 1998, The EMBO journal.
[57] M. Cappellini,et al. The expression of uridine diphosphate glucuronosyltransferase gene is a major determinant of bilirubin level in heterozygous β‐thalassaemia and in glucose‐6‐phosphate dehydrogenase deficiency , 1997, British journal of haematology.
[58] J. Clegg,et al. Molecular basis for dominantly inherited inclusion body beta-thalassemia. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[59] Hall,et al. Beta‐thalassaemia intermedia: is it possible consistently to predict phenotype from genotype? , 1998, British journal of haematology.
[60] M. Russell,et al. Blood and urinary nicotine in non-smokers , 1975, The Lancet.
[61] S. Thein,et al. Erythroblastic Inclusions in Dominantly Inherited β Thalassemias , 1997 .
[62] J. Clegg,et al. Thalassemia — a global public health problem , 1996, Nature Medicine.
[63] C. Thompson,et al. The interaction of anti 3.7 type quadruplicated alpha-globin genes and heterozygous beta-thalassemia. , 1989, Hemoglobin.
[64] D. Labie,et al. Common haplotype dependency of high G gamma-globin gene expression and high Hb F levels in beta-thalassemia and sickle cell anemia patients. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[65] D. Weatherall,et al. The role of genomics in studying genetic susceptibility to infectious disease. , 1997, Genome research.
[66] D. Weatherall,et al. Genetic influences on bone disease in thalassemia. , 1998 .
[67] G. Sciarratta,et al. The Silent Carrier of β‐Thalassemia , 1985 .
[68] Stylianos E. Antonarakis,et al. Abnormal RNA processing due to the exon mutation of βE-globin gene , 1982, Nature.
[69] S. Boyer,et al. Fetal hemoglobin restriction to a few erythrocytes (F cells) in normal human adults. , 1975, Science.
[70] U. Wolf. Identical mutations and phenotypic variation , 1997, Human Genetics.
[71] W. Wood,et al. β + Thalassaemia—Portuguese type: clinical, haematological and molecular studies of a newly defined form of β thalassaemia , 1983 .
[72] G. Stamatoyannopoulos,et al. Triplicated alpha-globin loci in humans. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[73] J. Clegg,et al. The Hemoglobin E Syndromes , 1998, Annals of the New York Academy of Sciences.
[74] S. Perrotta,et al. Osteoporosis in beta-thalassaemia major patients: analysis of the genetic background. , 2000 .
[75] L. Maquat,et al. Intron function in the nonsense-mediated decay of beta-globin mRNA: indications that pre-mRNA splicing in the nucleus can influence mRNA translation in the cytoplasm. , 1998, RNA.
[76] D. Weatherall,et al. From genotype to phenotype: genetics and medical practice in the new millennium. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[77] J. Clegg,et al. Is hemoglobin instability important in the interaction between hemoglobin E and beta thalassemia? , 1998, Blood.
[78] S. Thein. DOMINANT β THALASSAEMIA: MOLECULAR BASIS AND PATHOPHYSIOLOGY , 1992 .
[79] E. Rachmilewitz,et al. Beta O-thalassemia intermedia , 1978 .